Cell distribution after intracoronary bone marrow stem cell delivery in damaged and undamaged myocardium: implications for clinical trials.

Virginie Forest 1, 2 Ashok Tirouvanziam 3 Christian Perigaud 2, 3 Sarah Fernandes 1, 2 Marion Fusellier 4 Jean-Claude Desfontis 4 Claire Toquet 5 Marie-Françoise Heymann 2, 5, 6 Dominique Crochet 1, 2, 3 Patricia Lemarchand 1, 2, 3, *
* Auteur correspondant
1 Institut du thorax
2 Institut Fédératif de Recherche Thérapeutique 26 (IFR26)
3 ITX - unité de recherche de l'institut du thorax UMR1087 UMR6291
4 UPSP 5304 - Animal Pathophysiology and Functional Pharmacology Unit
5 Service d'Anatomo-pathologie
6 Physiopathologie de la Résorption Osseuse et Thérapie des Tumeurs Osseuses Primitives
Abstract : ABSTRACT : INTRODUCTION : Early randomized clinical trials of autologous bone marrow cardiac stem cell therapy have reported contradictory results highlighting the need for a better evaluation of protocol designs. This study was designed to quantify and compare whole body and heart cell distribution after intracoronary or peripheral intravenous injection of autologous bone marrow mononuclear cells in a porcine acute myocardial infarction model with late reperfusion. METHODS : Myocardial infarction was induced using balloon inflation in the left coronary artery in domestic pigs. At seven days post-myocardial infarction, 1 x 10(8) autologous bone marrow mononuclear cells were labeled with fluorescent marker and/or 99mTc radiotracer, and delivered using intracoronary or peripheral intravenous injection (leg vein). RESULTS : Scintigraphic analyses and Upsilon-emission radioactivity counting of harvested organs showed a significant cell fraction retained within the heart after intracoronary injection (6 +/- 1.7% of injected radioactivity at 24 hours), whereas following peripheral intravenous cell injection, no cardiac homing was observed at 24 hours and cells were mainly detected within the lungs. Importantly, no difference was observed in the percentage of retained cells within the myocardium in the presence or absence of myocardial infarction. Histological evaluation did not show arterial occlusion in both animal groups and confirmed the presence of bone marrow mononuclear cells within the injected myocardium area. CONCLUSIONS : Intravenous bone marrow mononuclear cell injection was ineffective to target myocardium. Myocardial cell distribution following intracoronary injection did not depend on myocardial infarction presence, a factor that could be useful for cardiac cell therapy in patients with chronic heart failure of non-ischemic origin or with ischemic myocardium without myocardial infarction.
Type de document :
Article dans une revue
Stem Cell Research and Therapy, BioMed Central, 2010, 1 (1), pp.4. 〈10.1186/scrt4〉
Liste complète des métadonnées

Littérature citée [30 références]  Voir  Masquer  Télécharger
http://www.hal.inserm.fr/inserm-00663767
Contributeur : Ed. Bmc <>
Soumis le : vendredi 27 janvier 2012 - 14:25:01
Dernière modification le : lundi 25 juin 2018 - 09:33:46
Document(s) archivé(s) le : samedi 28 avril 2012 - 02:32:56

Fichiers

scrt4.pdf
Fichiers éditeurs autorisés sur une archive ouverte

Identifiants

Collections

UNIV-NANTES | PHY-OS | THORAX-UMR

Citation

Virginie Forest, Ashok Tirouvanziam, Christian Perigaud, Sarah Fernandes, Marion Fusellier, et al.. Cell distribution after intracoronary bone marrow stem cell delivery in damaged and undamaged myocardium: implications for clinical trials.. Stem Cell Research and Therapy, BioMed Central, 2010, 1 (1), pp.4. 〈10.1186/scrt4〉. 〈inserm-00663767〉

Exporter

BibTeX TEI DC DCterms EndNote

Partager

Métriques

Consultations de la notice

365

Téléchargements de fichiers

204

Contact

support.ccsd.cnrs.fr
hal.support@ccsd.cnrs.fr
Logo CCSD